Cancer, cognition, and COVID: delivering direct-to-home teleneuropsychology services to neuro-oncology patients.
Cancer, cognition, and COVID: delivering direct-to-home teleneuropsychology services to neuro-oncology patients.
复制标题
DOI：
10.1093/nop/npab021
复制
发表时间：
2021-08
影响因子：
2.7
通讯作者：
Parsons MW
中科院分区：
文献类型：
--
作者：
Gardner MM;Aslanzadeh FJ;Zarrella GV;Braun SE;Loughan AR;Parsons MW
The COVID-19 pandemic induced rapid adoption of telemedicine services for neuro-oncology patients at an increased risk of infection. Neuropsychological assessment is important to neuro-oncology care yet challenging to complete outside of a structured testing environment. Teleneuropsychology (TNP) has been explored in limited populations and proven feasible and reliable. Conducting TNP visits directly to patients’ home (DTH) had minimal prior study. We used two voluntary surveys to examine acceptance (patients) and feasibility (providers) of DTH-TNP at two regionally diverse medical institutions providing neuropsychological services to neuro-oncology patients from April to September 2020. A total of 119 patients were scheduled during the study period, 79 of whom completed neuropsychological testing via DTH-TNP. Neuropsychology providers completed surveys on 68 of these encounters (86%). In 98% of cases, neuropsychologists were able to achieve or partially achieve the individually defined goals of their assessment. Common problems reported included patient dysregulation (16%) and slow/unreliable internet (15%). Of the 52 patients who responded, 98% were satisfied with the DTH-TNP experience, and 92% would recommend the virtual visit to others. All respondents felt understood by the examiner (100%) and the majority denied technical difficulties (90%), communication challenges (94%), or privacy concerns (98%). Patients reported reduced risk of infection and saved travel time as favorable aspects of DTH-TNP. These preliminary results suggest neuro-oncology patients find DTH-TNP acceptable and neuropsychologists find it a feasible practice, while also recognizing its limitations. Results suggest that further study of DTH-TNP (eg, reliability, validity) for neuro-oncology patients is warranted.
登录
查看更多内容
影响因子：
2.6
作者：
Bilder, Robert M.;Postal, Karen S.;Woodhouse, Jonathan
通讯作者：
Woodhouse, Jonathan
影响因子：
2
作者：
Daggubati, Lekhaj C.;Eichberg, Daniel G.;Zacharia, Brad E.
通讯作者：
Zacharia, Brad E.
影响因子：
2.6
作者：
Wadsworth, Hannah E.;Galusha-Glasscock, Jeanine M.;Cullum, C. Munro
通讯作者：
Cullum, C. Munro
影响因子：
4.7
作者：
Hildebrand, R;Chow, H;Wass, P
通讯作者：
Wass, P
影响因子：
4.7
作者：
Dang, Stuti;Gomez-Orozco, Carlos A.;Levis, Silvina
通讯作者：
Levis, Silvina